Herein, we propose a novel and generalizable chemo-genetic enzyme engineering approach that 39 enables the fabrication of modular, multistep, biocatalytic, continuous-flow reactors using cofactor-40 dependent enzymes, thereby extending the utility of biocatalysis for continuous-flow production 41 systems and cell-free metabolic engineering 11 . 42
flexible 'swinging arm' that is covalently attached to the protein. We have adopted a similar strategy, 49 whereby a flexible swinging arm covalently attaches a cofactor to a synthetic, multidomain protein 50 and delivers that cofactor to the different active sites of the fusion protein, allowing its simultaneous 51 use and recycling, while preventing its diffusion (Figure 1) . 52
The general design of our nanomachines is shown in Figure 1 . Each nanomachine is comprised of three 53 modules: a catalytic module that drives the desired synthesis reaction, a cofactor recycling module 54 that regenerates the cofactor after use, and an immobilization module that allows site-specific, 55 covalent conjugation to an activated surface. The modular design is intended to allow a small number 56 of immobilization and cofactor recycling modules to be used with a wide variety of synthesis modules, 57 thereby enabling diverse synthetic reactions using a relatively small library of core nanomachine 58 components. It is envisaged that multiple nanomachines could be combined in series or in networks 59 to produce a 'nanofactory' for the synthesis of complex chiral molecules using multi-enzyme cascade 60 reactions. 61
In our design, the three modules of each nanomachine were encoded by a single gene for production 62 in E. coli as a single protein with a short spacer (2-20 amino acids, Online methods) separating each 63 module. A modified cofactor was designed that could be conjugated to the spacer between the 64 catalytic and cofactor recycling modules. We used a maleimide-functionalized polyethylene glycol 65 (PEG) for the flexible linker to allow movement of the modified cofactor between active sites. In silico 66 modelling suggested that a chain length of twenty-four ethylene glycol units was long enough to allow 67 ingress into both active sites. The amino acid spacer that separated the catalytic and cofactor recycling 68 modules contained a single solvent exposed cysteine residue, which provided an accessible thiol group 69 with which to tether the maleimide-functionalized PEGylated cofactor (Figure 1) . 70
71

Assembling the nanomachines
72
For the prototype nanofactory we selected D-fagomine synthesis -coupling three nanomachines in 73 series to convert glycerol (1) and 3-aminopropanal (3) into a chiral drug precursor (Figure 2 ). Total 74 synthesis of this anti-diabetic piperidine iminosugar using non-biological catalysts is challenging, due 75 to the complexity conferred by its two stereocenters, and eight possible diastereomers, with even 76 recent advances only resulting in yields up to 65% of each diastereomer 16 . In our nanofactory (a 77 cascade of nanomachines), glycerol is converted to dihydroxyacetone phosphate (DHAP) (4) by 78 regiospecific phosphorylation and oxidation, via ATP and NAD + -dependent steps, respectively. A 79 subsequent aldolase-catalyzed stereoselective aldol addition with 3-aminopropanal yields (3S,4R)-80 amino-3,4-dihydroxy-2-oxyhexyl phosphate (3S,4R-ADHOP), which can be dephosphorylated with 81 phosphorylase and cyclized to form D-fagomine 17 (6). For the purposes of purification, we elected to 82 use the carboxybenzyl (Cbz)-protected derivative of 3-aminopropanal, yielding N-Cbz-3S,4R-ADHOP 83 (5). 84
Prior comparison of enzymes that could be used for the first two steps of the model synthesis 18 had 85 suggested that the most suitable enzymes for glycerol phosphorylation were a Thermococcus 86 kodakarensis glycerol kinase (GlpKTk) and a Mycobacterium smegmatis acetate kinase (AceKMs). For 87 the NAD + -dependent production of DHAP from glycerol-3-phosphate (G3P), E. coli glycerol-3-88 phosphate dehydrogenase (G3PDEc) and the water-forming NADH oxidase from Clostridium 89 aminovalericum (NOXCa) were selected. The third reaction step is a cofactor-independent aldolase-90 catalyzed aldol addition. A monomeric fructose aldolase (FruA) homolog from Staphylococcus 91 carnosus was selected from a panel of five potential aldolases. Each of the enzymes incorporated into 92 the nanomachine fusion proteins were selected for their compatibility in batch reactions 18 , high 93 catalytic rates, relatively simple quaternary structures and thermostability (Supplementary Table 2) . 94
For the conjugation module, we used a serine hydrolase enzyme coupled with a suicide inhibitor 95 (trifluoroketone, TFK) that forms a site-specific and stable covalent bond between the inhibitor and 96 the catalytic serine residue 19 . Esterase E2 from Alicyclobacillus acidocaldarius (E2Aa) 20 was selected 97 for the serine hydrolase component as a highly stable, soluble, monomeric protein (Supplementary  98   Table 2 ). 99
The genes encoding GlpKTk and AceKMs were fused, such that GlpKTk formed the N-terminus of the 100 resultant protein and AceKMs formed the C-terminus (Fig. 2) . The two modules were separated by a 101 nineteen amino acid unstructured amino acid linker, containing a single, solvent-accessible cysteine 102 residue that was used subsequently as the attachment point for the maleimide functionalized PEG24-103
ATP ([GSS]3C[GSS]3)
. A similar gene fusion was constructed used G3PDEc and NOXCa, producing a 104 protein in which G3PDEc formed the N-terminus and NOXCa formed the C-terminus. The fused proteins 105 retained or in some cases improved their original catalytic functions (Table 1) , albeit some loss of 106 activity (both KM and kcat) was incurred for AceKMs and G3PDEc. The thermal stability of each of the 107 fused enzymes appeared to be independent of one another i.e. protein unfolding of the component 108 modules of each fusion are independent events (Supplementary Table 2) . 109
The gene encoding the conjugation module (E2Aa) was fused with both the glpKTk-aceKMs and g3pDEc-110 noxCa such that it formed the C-terminus of the encoded proteins (i.e., GlpKTk-AceKMs-E2Aa and G3PDEc-111 NOXCa-E2Aa). Addition of the conjugation module had little effect on the kinetic performance or 112 thermal stabilities of the other modules of each nanomachine (Table 1 & Supplementary Table 1) . The 113 conjugation module was highly efficient (86-98% immobilization efficiency), and the immobilized 114 enzymes retained their activity. This immobilization technique has the potential for broad applicability 115 to other biocatalytic systems. 116
The cofactors were modified (Online methods) by functionalization of the C6-adenine-amine of ADP 117 (7) or NAD + (12) to which a modified PEG24 was added ( Fig. 1; Supplementary Scheme 1) . The PEG24 118
linker included an N-hydroxysuccinimide ester that allowed reaction with the modified cofactor and a 119 maleimide group for conjugation with the fusion proteins. Conjugation of MAL-PEG24-2AE-ADP (11) 120
and MAL-PEG24-2AE-NAD + (13) to the nanomachines yielded enzymes that were active in batch 121
reactions without the addition of exogenous cofactor, with catalytic constants equivalent or superior 122 to individual enzyme components (Table 1 
Function of Nanofactory
129
The nanomachines were immobilized on TFK-activated agarose beads at densities of 1.6, 1.0 and 1.0 130 milligrams protein per gram wet beads for the phosphorylation, oxidation and aldolase nanomachines, 131 respectively, and packed into glass columns to produce three nanomachine packed bed reactor 132 columns: a phosphorylation column (23.1 mL packed volume), an oxidation column (25.7 mL packed 133 volume) and an aldol addition column (17.7 mL packed volume) (Figure 2) . 134
Individual performance data for each nanomachine reactor (Figure 3) . This is consistent with the expected yields based on kcat/KM 138 values of the loaded enzymes (Table 1 ), e.g., for the phosphorylation reactor, 36.9 mg protein per 139 column (2.7 nmol tethered biocatalysts) yielded 2.6 g product per litre (6.6 mM) per hour, equivalent 140 to the expected 1,399 nmol per nmol of enzyme per second. 141
As reported elsewhere, when the glycerol-3-phosphate oxidation reaction and aldolase reaction were 142 run in batch, yields were limited by product inhibition and substrate: product equilibrium, with 143 substrate conversion of 88% and 63% respectively 18, 21, 22 . In our reactors, the phosphorylation and 144 oxidation reactions were run to completion (i.e., complete 100% substrate conversion). It is likely that6 running the system as a continuous flow reaction prevented the build-up of reaction products and so 146 mitigated both product inhibition and equilibrium control, resulting in the high yields observed in our 147
reactors. 148
The turnover numbers for the cofactors exceeded 10,000 (~11,000 for the NAD + -dependant oxidation 149 reactor and ~17,000 for the ATP-dependant phosphorylation reactor; Figure 3a) . In each case the 150 reactions stopped because of the inactivation of one of the modules (AceKMs for the phosphotransfer 151 reactor; NOXCa for the oxidation reactor) rather than the loss of cofactor. It is reasonable to assume 152 that the turnover numbers would be higher if the enzymes were modified for greater stability, a 153 relatively facile exercise with modern enzyme engineering approaches 23, 24 . 154
The three reactors were then combined in series (Figure 2b The percent conversion dropped to 40% at higher flow rates (1.0 mL.min 
Conclusions
164
We have developed and successfully implemented a general chemo-genetic protein engineering 165 strategy that enables cofactor-dependent, continuous-flow biocatalysis via the use of nanomachines: 166 single molecule multi-enzyme biocatalysts that retain and recycle their cofactors. The engineered 167 biocatalysts were used to construct a three step continuous-flow reactor system (a 'nanofactory') that 168 performed well, with superior yields of D-fagomine precursor compared to chemical syntheses 16 , as 169 well as high space-time yields and total turnover numbers for the catalysts and cofactors. Additionally, 170 use of the biocatalysts in a continuous-flow system appears to have mitigated production inhibition 171 and equilibrium control of yield, allowing very high substrate conversion. 172
We have used sugar analog synthesis as a model for our prototype 'nanofactory'; however, we believe 173 that this approach is generalizable because of the modular design principles used in the design of both 174 the 'nanomachines' and the 'nanofactories'. For the nanomachines, we envision a small library of 175 conjugation and cofactor recycling modules that could be used in conjunction with a larger library of 176 catalysis modules to provide access to a wide range of reactions. and control the system, as per manufacturer's instructions. All restriction enzymes and T4 DNA ligase 324 enzymes used for DNA manipulation were purchased from New England Bioabas (NEB, USA). All PEG 325 compounds were purchased from Quanta BioDesign Ltd (Plain City, OH, USA) and used as received. All 326 other reagents and solvents were obtained from Sigma-Aldrich (Merck), Acros Organics or TCI 327
Chemicals and used as-purchased. Nuclear Magnetic resonance (NMR) spectra were recorded with a 328
Bruker Avance 400 MHz spectrometer in the deuterated solvents as specified. Chemical shifts (δ) were 329 calibrated against residual solvent peaks and are quoted in ppm relative to TMS. 
Expression of individual enzymes and bi-enzymatic fusion proteins.
496
The expression plasmids outlined above were used to transform E. coli BL21 DE3 Star (Invitrogen,  497 ThermoFisher Scientific, USA), using Luria agar containing 100 µg mL -1 ampicillin as a selective growth 498 medium. Cells were cultured overnight in Luria broth containing 100 µg mL -1 ampicillin at 37 °C and 499 shaken at 200 rpm, then induced for 2, 4, 6 and 24 h with either arabinose or isopropyl β-D-1-500 thiogalactopyranoside (IPTG) at 0.2 M and 1 mM final concentration, respectively (see Supplementary 501 Table 1 for details). Cultures were then harvested, by centrifugation at 8000 g, resuspended in one 502 tenth culture volume of resuspension buffer (50 mM Tris-Cl, 250 mM NaCl, pH 7.5) and lyzed with 503
Bugbuster TM (Novagen). Protein expression was analyzed by SDS-PAGE separation (4-12% Bolt Bis-Tris 504
Plus Polyacrylamide Gel with MES SDS running buffer (Invitrogen, USA) and visualized with NuBlue 505 (Novagen). The optimal expression time (Supplementary Table 1 ) was selected and large scale 506 expression cultures of 1-2 L prepared in the same way as above except that cells were lysed by passage 507 through an EmulsiFlex-C5 cell homogenizer (Avestin) at 20,000 psi , 4 °C and cellular debris removed 508 by centrifugation (40,000 x g, 15 min, 4 °C). Protein was first purified from cell free lysates by IMAC 509 purification of HIS-tagged protein by elution with resuspension buffer (50 mM Tris-Cl, 250 mM NaCl, 510 pH 7.5) containing increasing concentration of imidazole from NiNTA-sepharose (Hi5 HIS-TRAP, GE 511 Healthcare). The desired protein fractions were then pooled and further purified using a Superdex 200 512 size exclusion column (GE Healthcare). Pooled fractions were then concentrated and stored at 4 °C, or 513 Each of the purified individual and bi-enzymatic fusion proteins were then characterised in terms of 519 catalytic activity (Table 1) Expression of GlpKTk-AceKMs-E2Aa.
532
The expression of GlpKTk-AceKMs-E2Aa in E. coli BL21 DE3 Star (Invitrogen, ThermoFisher Scientific, USA) 533 cells transformed with the plasmid pETCC2-GlpKTk-AceKMs-E2Aa (pCJH4; Supplementary Table 1) was 534 examined after induction at 15 °C for 18 h with 1 mM IPTG as inducer, and the oligomeric state related 535 to fusion protein activity, using glycerol kinase activity as a proxy for all three activities (Supplementary 536 Table 1 ) were cultured in an XRS 20 bioreactor (Pall Corporation, USA) using a 2 litre volume of M9 565 minimal medium, with 1% (w/v) ammonium sulphate and 1% (w/v) glucose as nitrogen and carbon 566 source respectively and supplemented with 100 µg mL -1 ampicillin. After initial growth at 37 °C, the 567 temperature was reduced to 25 o C prior to induction, when the OD600nm reached 2.2. The optical 568 density of the culture at induction was OD600nm 2.9 and 1.6 mL of 20% arabinose and IPTG to 1 mM 569 were added to induce. The glucose feed was started 7 h post-induction to maintain 1% glucose and 570 cells were harvested 22 h post-induction, when OD600nm was 21.6. 571 572 Cell paste (2 g) was resuspended in 50 mL 50 mM Tris, 300 mM NaCl pH 8 containing 0.1 mM Tris-(2-573 carboxyethyl)phosphine (TCEP; Sigma-Aldrich), 0.5 mg mL -1 lysozyme (Sigma-Aldrich), 2 mM 574 phenylmethane sulfonyl fluoride (PMSF; Sigma-Aldrich), one EDTA-Free Complete Protease inhibitor 575 tablet (Roche) and 250 Units Benzonase (Merck Millipore). Following resuspension, the cells were 576 ruptured by passage three times through an EmulsiFlex-C5 cell homogenizer (Avestin) at 15,000 psi at 577 4 °C and cellular debris removed by centrifugation (40,000 x g, 15 min, 4 °C). The lysate was filtered 578 (0.45 μm) and applied to a 5 mL HisTrap FF column (GE Healthcare) equilibrated in 50 mM Tris, 300 579 mM NaCl pH 8 containing 0.1 mM TCEP. The column was washed with 40 mM imidazole in the same 580 buffer then the bound protein eluted with 300 mM imidazole in the same buffer. The eluted protein 581 was subjected to gel filtration on a Superdex 200 gel filtration column (GE Healthcare) equilibrated 582 with 50 mM citrate, 200 mM NaCl pH 6 containing 1 mM TCEP with the absorbance of the eluted 583 protein monitored at 280 and 450 nm. Fractions eluting from 158 -192 mL were pooled and 584 concentrated to 0.94 mg mL -1
. 585
G3PDEc-NOXCa-Est2Aa eluted in a broad peak from the gel filtration column, with some protein eluting 586 in the void volume (Supplementary Figure 2) . The final pool was > 95% pure as estimated by SDS-PAGE 587 and was found to have specific activities of 16 U mg -1 for esterase and 31 U mg -1 for NADH oxidase. 588
589
Expression and purification of FruASc-Est2Aa.
590
FruASc was selected as the preferred aldolase for the nanofactory based on its enantioselectivity (3S, 591 4R-ADHOP), oligomeric structure, stability, catalytic rate (Supplementary Table 2 ) and previous 592 success using this enzyme in multi-enzyme cascades to produce similar chiral sugars tethered 2AE-ADP-PEG24-MAL-GlpKTK-AceKMs-Est2Aa was found to convert 10 mM glycerol and 10 mM 676 acetyl phosphate to glycerol-3-phosphate with high efficiency (Supplementary Figure 3a) . 677
678
Tethering of MAL-PEG24-2AE-NAD + to G3PDEc-NOXCa-Est2Aa in solution. spectrometry. The tethered 2AE-NAD + -PEG24-MAL-G3PDEc-NOXCa-Est2Aa was found to convert 10 mM 683 glycerol-3-phosphate and to DHAP with high efficiency (Supplementary Figure 3b) . 684
Supplementary Figure 3. Functional tethering of modified cofactors MAL-PEG24-2AE-ADP (a) and 686
MAL-PEG24-2AE-NAD + (b) to nanomachine fusion proteins. a, Glycerolkinase activity with and without 687 the addition of 100 μM ATP catalyzed by either 2AE-ADP-PEG24-MAL-GlpKTk-AceKMs-E2Aa or by GlpKTk-688 AceKMs-E2Aa was then coupled with glycerol-3-phosphate dehydrogenase activity (G3PDEc-NOXCa-E2Aa) 689 and aldolase activity (FruASc with glyceraldehyde-3-phosphate as added donor substrate) to 690 demonstrate the production of fructose-1,6-biphosphate from 10 mM glycerol using 2AE-ADP-PEG24-691 MAL-GlpKTk-AceKMs-E2Aa. A scheme of the three step reaction involved is illustrated beneath the graph. 692 b, Glycerol-3-phosphate dehydrogenase activity (DHAP production rate) using 10 mM glycerol-3-693 phosphate with and without the addition of 100 μM NAD + catalyzed by 2AE-NAD 
930
HPLC separation was conducted using an Agilent Eclipse XDB column (50 mm x 4.6 mm) with isocratic 931 elution using 75% solvent A and 25% solvent B. Solvent A: 20 mM tetrabutylammonium phosphate 932
